Header Logo

Connection

David Bennett to Animals

Back to Details
This is a "connection" page, showing publications David Bennett has written about Animals.
David Bennett
Connection Strength
1.543
Animals
  1. The synaptic pathology of cognitive life?. Dialogues Clin Neurosci. 2019 09; 21(3):271-279.
    View in: PubMed
    Score: 0.094
  2. Cognitive and social lifestyle: links with neuropathology and cognition in late life. Acta Neuropathol. 2014 Jan; 127(1):137-50.
    View in: PubMed
    Score: 0.063
  3. An inflection point in gene discovery efforts for neurodegenerative diseases: from syndromic diagnoses toward endophenotypes and the epigenome. JAMA Neurol. 2013 Jun; 70(6):719-26.
    View in: PubMed
    Score: 0.061
  4. Assessment of corneal hydration sensing in the terahertz band: in vivo results at 100 GHz. J Biomed Opt. 2012 Sep; 17(9):97008-1.
    View in: PubMed
    Score: 0.058
  5. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022 06 15; 17(1):42.
    View in: PubMed
    Score: 0.029
  6. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol. 2022 07; 144(1):59-79.
    View in: PubMed
    Score: 0.028
  7. Higher Dietary Intake of Advanced Glycation End Products Is Associated with Faster Cognitive Decline in Community-Dwelling Older Adults. Nutrients. 2022 Mar 31; 14(7).
    View in: PubMed
    Score: 0.028
  8. Late-life physical activity relates to brain tissue synaptic integrity markers in older adults. Alzheimers Dement. 2022 11; 18(11):2023-2035.
    View in: PubMed
    Score: 0.028
  9. Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies. Neurobiol Dis. 2021 12; 161:105542.
    View in: PubMed
    Score: 0.027
  10. Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice. Acta Neuropathol Commun. 2021 07 27; 9(1):129.
    View in: PubMed
    Score: 0.027
  11. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease. Nat Neurosci. 2021 06; 24(6):786-798.
    View in: PubMed
    Score: 0.026
  12. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2021 04 16; 16(1):26.
    View in: PubMed
    Score: 0.026
  13. PLD3 is a neuronal lysosomal phospholipase D associated with ?-amyloid plaques and cognitive function in Alzheimer's disease. PLoS Genet. 2021 04; 17(4):e1009406.
    View in: PubMed
    Score: 0.026
  14. Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample. Acta Neuropathol. 2021 05; 141(5):755-770.
    View in: PubMed
    Score: 0.026
  15. A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology. Neurobiol Dis. 2021 01; 148:105150.
    View in: PubMed
    Score: 0.026
  16. A second X chromosome contributes to resilience in a mouse model of Alzheimer's disease. Sci Transl Med. 2020 08 26; 12(558).
    View in: PubMed
    Score: 0.025
  17. Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models. Cell Rep. 2020 07 14; 32(2):107908.
    View in: PubMed
    Score: 0.025
  18. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020 05; 26(5):769-780.
    View in: PubMed
    Score: 0.025
  19. Brain mural cell loss in the parietal cortex in Alzheimer's disease correlates with cognitive decline and TDP-43 pathology. Neuropathol Appl Neurobiol. 2020 08; 46(5):458-477.
    View in: PubMed
    Score: 0.024
  20. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020 01; 26(1):131-142.
    View in: PubMed
    Score: 0.024
  21. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat Genet. 2019 11; 51(11):1624-1636.
    View in: PubMed
    Score: 0.024
  22. Regulation of lifespan by neural excitation and REST. Nature. 2019 10; 574(7778):359-364.
    View in: PubMed
    Score: 0.024
  23. Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease. Cell Rep. 2019 10 08; 29(2):301-316.e10.
    View in: PubMed
    Score: 0.024
  24. 3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice. Commun Biol. 2019; 2:360.
    View in: PubMed
    Score: 0.024
  25. cindr, the Drosophila Homolog of the CD2AP Alzheimer's Disease Risk Gene, Is Required for Synaptic Transmission and Proteostasis. Cell Rep. 2019 08 13; 28(7):1799-1813.e5.
    View in: PubMed
    Score: 0.023
  26. Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects. Sci Rep. 2018 09 03; 8(1):13119.
    View in: PubMed
    Score: 0.022
  27. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology. J Clin Invest. 2018 10 01; 128(10):4297-4312.
    View in: PubMed
    Score: 0.022
  28. Tau Activates Transposable Elements in Alzheimer's Disease. Cell Rep. 2018 06 05; 23(10):2874-2880.
    View in: PubMed
    Score: 0.022
  29. Fish Intake, Genetic Predisposition to Alzheimer Disease, and Decline in Global Cognition and Memory in 5 Cohorts of Older Persons. Am J Epidemiol. 2018 05 01; 187(5):933-940.
    View in: PubMed
    Score: 0.021
  30. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018 04; 14(4):535-562.
    View in: PubMed
    Score: 0.021
  31. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's A?42, Tau, TREM2, and TYROBP in Drosophila models. Genome Med. 2018 03 29; 10(1):26.
    View in: PubMed
    Score: 0.021
  32. A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer's Disease. Genetics. 2018 05; 209(1):51-64.
    View in: PubMed
    Score: 0.021
  33. A? mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci. 2018 01 31; 38(5):1085-1099.
    View in: PubMed
    Score: 0.021
  34. Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of?Selective Neuronal Vulnerability. Stem Cell Reports. 2017 12 12; 9(6):1868-1884.
    View in: PubMed
    Score: 0.021
  35. A translational approach to capture gait signatures of neurological disorders in mice and humans. Sci Rep. 2017 06 12; 7(1):3225.
    View in: PubMed
    Score: 0.020
  36. Selective lowering of synapsins induced by oligomeric a-synuclein exacerbates memory deficits. Proc Natl Acad Sci U S A. 2017 06 06; 114(23):E4648-E4657.
    View in: PubMed
    Score: 0.020
  37. Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease. Antioxid Redox Signal. 2017 Dec 01; 27(16):1269-1280.
    View in: PubMed
    Score: 0.020
  38. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample. Mol Neurodegener. 2017 03 20; 12(1):26.
    View in: PubMed
    Score: 0.020
  39. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
    View in: PubMed
    Score: 0.019
  40. Soluble Conformers of A? and Tau Alter Selective Proteins Governing Axonal Transport. J Neurosci. 2016 09 14; 36(37):9647-58.
    View in: PubMed
    Score: 0.019
  41. The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism. Acta Neuropathol. 2016 10; 132(4):503-14.
    View in: PubMed
    Score: 0.019
  42. NMNAT2:HSP90 Complex Mediates Proteostasis in Proteinopathies. PLoS Biol. 2016 06; 14(6):e1002472.
    View in: PubMed
    Score: 0.019
  43. Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense?oligonucleotides. EMBO Mol Med. 2016 04 01; 8(4):328-45.
    View in: PubMed
    Score: 0.019
  44. New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat Commun. 2016 Feb 01; 7:10495.
    View in: PubMed
    Score: 0.018
  45. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.018
  46. Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener. 2015 Dec 02; 10:65.
    View in: PubMed
    Score: 0.018
  47. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers. PLoS One. 2015; 10(10):e0139233.
    View in: PubMed
    Score: 0.018
  48. Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains. Mol Neurobiol. 2016 10; 53(8):5066-78.
    View in: PubMed
    Score: 0.018
  49. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet. 2015 Dec 01; 24(23):6721-35.
    View in: PubMed
    Score: 0.018
  50. Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2015; 47(2):385-402.
    View in: PubMed
    Score: 0.017
  51. 24-hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex. PLoS Genet. 2014 Nov; 10(11):e1004792.
    View in: PubMed
    Score: 0.017
  52. Life extension factor klotho enhances cognition. Cell Rep. 2014 May 22; 7(4):1065-76.
    View in: PubMed
    Score: 0.016
  53. REST and stress resistance in ageing and Alzheimer's disease. Nature. 2014 03 27; 507(7493):448-54.
    View in: PubMed
    Score: 0.016
  54. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol. 2014 Apr; 254:78-89.
    View in: PubMed
    Score: 0.016
  55. Caspase-6 activity in the CA1 region of the hippocampus induces age-dependent memory impairment. Cell Death Differ. 2014 May; 21(5):696-706.
    View in: PubMed
    Score: 0.016
  56. PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and A?. J Neurosci. 2013 Jun 26; 33(26):10729-40.
    View in: PubMed
    Score: 0.015
  57. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell. 2013 Apr 25; 153(3):707-20.
    View in: PubMed
    Score: 0.015
  58. The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease. J Neurosci. 2012 Nov 21; 32(47):16857-71a.
    View in: PubMed
    Score: 0.015
  59. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.014
  60. Motor axonal regeneration after partial and complete spinal cord transection. J Neurosci. 2012 Jun 13; 32(24):8208-18.
    View in: PubMed
    Score: 0.014
  61. Functional links between A? toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science. 2011 Dec 02; 334(6060):1241-5.
    View in: PubMed
    Score: 0.014
  62. Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain. Synapse. 2011 Aug; 65(8):763-70.
    View in: PubMed
    Score: 0.013
  63. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet. 2011 Feb 11; 88(2):232-8.
    View in: PubMed
    Score: 0.013
  64. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2009 Jan; 68(1):48-58.
    View in: PubMed
    Score: 0.011
  65. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron. 2008 Dec 26; 60(6):988-1009.
    View in: PubMed
    Score: 0.011
  66. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging. 2006 Nov; 27(11):1644-57.
    View in: PubMed
    Score: 0.009
  67. Mitochondrial DNA rearrangements in aging human brain and in situ PCR of mtDNA. Neurobiol Aging. 1999 Sep-Oct; 20(5):565-71.
    View in: PubMed
    Score: 0.006
  68. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther. 1987 Mar; 240(3):737-46.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.